SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-001667
Filing Date
2023-02-14
Accepted
2023-02-14 09:30:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 CUE BIOPHARMA, INC. p23-0869sc13g.htm SC 13G 72235
  Complete submission text file 0000902664-23-001667.txt   73770
Mailing Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022
Business Address 717 5TH AVENUE 16TH FL. NEW YORK NY 10022 212-257-4330
Slate Path Capital LP (Filed by) CIK: 0001559706 (see all company filings)

IRS No.: 800807580 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Subject) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90232 | Film No.: 23623438
SIC: 2834 Pharmaceutical Preparations